A Nurse-Led Educational Intervention for Patients With Type 1 Diabetes Using Continuous Glucose Monitoring.

There was no control group and no randomization, and all patients continued regular follow-up care, so the study cannot show the session alone caused the changes. The session included scanning frequency coaching, barrier discussion, goal setting, and interpretation of glucose values and trend arrows, so scanning behavior alone cannot be isolated. Baseline glucose data came from 14 days with 59.5% sensor active time, below the 70% often needed for accurate 3-month estimates. Follow-up was only 12 weeks, so long-term sustainability was not assessed. Participants had type 1 diabetes, had used the sensor for at least 6 months, and had prior Flash education, so new users were not studied. The study was single-center and recruited 34 patients consecutively by phone from one hospital diabetes technology unit.

The authors report no specific funding. They state they did not receive research support or compensation from Abbott. However, some authors report consultant fees, speaking honoraria, or consulting honoraria from companies including Abbott, Dexcom, Roche, Medtronic, Novalab, Ascensia, Novo Nordisk, Lilly, Sanofi, and Viatris.